Fenofibrate reduces tumor necrosis factor-α serum concentration and adipocyte secretion of hypercholesterolemic rabbits

Clinica Chimica Acta

Volumn 347, Issue 1-2, 2004, Pages 145-150

  Zhao, Shui Ping ^a   Wu, Jie ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Adipocytes; Fenofibrate; Hypercholesterolemia; TNF

Indexed keywords

CHOLESTEROL; FENOFIBRATE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TUMOR NECROSIS FACTOR ALPHA;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL CULTURE; CELL SECRETION; CHOLESTEROL DIET; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEEDING; HYPERCHOLESTEROLEMIA; MALE; MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RABBIT; SERUM; SUPERNATANT; WEIGHT REDUCTION;

ADIPOCYTES; ANIMALS; ANTILIPEMIC AGENTS; BODY WEIGHT; CELLS, CULTURED; DEPRESSION, CHEMICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERCHOLESTEROLEMIA; LIPIDS; MALE; PROCETOFEN; RABBITS; TUMOR NECROSIS FACTOR-ALPHA;

ORYCTOLAGUS CUNICULUS;

EID: 4143097037     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2004.04.001     Document Type: Article

References (29)

1. Alexander R.W. Inflammation and coronary artery disease. N. Engl. J. Med. 331:1994;468-469
2. Cesari M., Penninx B.W., Newman A.B., et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation. 108(11):2003;2317-2322
3. Lei X., Buja L.M. Detection and localization of tumor necrosis factor-α in WHHL rabbit arteries. Atherosclerosis. 125:1996;81-89
4. Biasucci L.M., Vitelli A., Liuzzo G., et al. Elevated levels of interleukin-6 in unstable angina. Circulation. 94:1996;874-877
5. Aggarwal B.B. Human cytokines. Aggarwal B.B., Gutterman J.U.:1992;270 Blackwell, Boston
6. Rus H.G., Niculescu F., Vlaicu R. Tumor necrosis factor-α in human arterial wall with atherosclerosis. Atherosclerosis. 89:1991;247
7. Madej A., Okopien B., Kowalski J., et al. Effects of fenofibrate on plasma cytokine concentrations in patients with atherosclerosis and hyperlipoproteinemia II b. Int. J. Clin. Pharmacol. Ther.a. 36:1998;345-354
8. Waage A., Bakke O. Glucocorticoids suppress the production of tumor necrosis factor by lipopolysaccaride-stimulated human monocytes. Immunology. 63:1988;299-302
9. Mijatovic T., Kruys V., Caput D., et al. Interleukin-4 and -13 inhibit tumor necrosis factor alpha mRNA translational activation in lipopolysaccaride-induced mouse macrophages. J. Biol. Chem. 22:1997;14394-14398
10. Sewter C.P., Digby J.E., Blows F., et al. Regulation of tumor necrosis factor-alpha release from human adipose tissue in vitro. J. Endocrinol. 163:1999;33-38
11. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science (Wash. D.C.). 259:1993;87-91
12. Hotamisligil G.S., Spiegelman B.M. TNF-α: a key component of obesity-diabetes link. Diabetes. 43:1994;1271-1278
13. Lee H.J., Choi S.S., Park M.K., et al. Fenofibrate lowers abdominal and skeletal adiposity and improves insulin sensitivity in OLETF rats. Biochem. Biophys. Res. Commun. 296:2002;293-302
14. Guerre-Millo M., Gervois P., Raspe E., et al. Peroxisome proliferator-activated receptor α activators improve insulin sensitivity and reduce adiposity. J. Biol. Chem. 275:2000;16638-16642
15. Delerive P., Fruchart J.C., Staels B. Peroxisome proliferator-activated receptor in inflammation control. J. Endocrinol. 169:2001;453-459
16. Rodbell M. Effects of hormones on glucose metabolism and lipolysis. J. Biol. Chem. 239:1963;375-380
17. Zhang H.H., Kumar S., Barnett A.H., Eggo M.C. Ceiling culture of mature human adipocytes: use in studies of adipocyte functions. J. Endocrinol. 164:2000;119-128
18. Winkler G., Kiss S., Keszthelyi L., et al. Expression of tumor necrosis factor (TNF)-alpha protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-alpha, soluble serum TNF-receptor-2 concentrations and C-peptide level. Eur. J. Endocrinol. 149:2003;129-135
19. Hotamisligil G.S., Peraldi P., Budavari A., et al. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-α and obesity-induced insulin resistance. Science. 271:1996;665
20. Bullo M., Garcia-Lorda P., Megias I., Salas-Salvado J. Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes. Res. 11:2003;525-531
21. Yudkin J.S., Stehouwer C.D.A., Emeis J.J., Coppack S.W. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction. A potential role for cytokines originating from adipose tissue? Arterioscler. Thromb. Vasc. Biol. 19:1999;972-978
22. Samad F., Uysal K.T., Wiesbrock S.M., et al. Tumor necrosis factor α is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1. Proc. Natl. Acad. Sci. U. S. A. 96:1999;6902-6907
23. Koukkunen H., Penttila K., Kemppainen A., et al. C-reactive protein, fibrinogen, interleukin-6 and tumor necrosis factor alpha in the prognostic classification of unstable angina pectoris. Am. Med. 33:2001;37-47
24. Han S.N., Leka L.S., Lichtenstein A.H., et al. Effect of hydrogenated and saturated, relative to polyunsaturated, fat on immune and inflammatory responses of adults with moderate hypercholesterolemia. J. Lipid Res. 43:2002;445-452
25. Barath P., Cao J., Forrester J.S. Low density lipoprotein activates monocytes to express tumor necrosis factor. FEBS. 277:1990;180
26. Torra I.P., Chinetti G., Duval C., et al. Peroxisome proliferator- activated receptors: from transcriptional control to clinical practice. Curr. Opin. Lipidol. 12:2001;245-254
27. Hennuyer N., Poulain P., Madsen L., et al. Beneficial effects of fibrates on apolipoprotein A-I metabolism occur independently of any peroxisome proliferative response. Circulation. 99:1999;2445-2451
28. Zhao S.P., Ye H.J., Zhou H.N., et al. Gemfibrozil reduces release of tumor necrosis factor-α in peripheral blood mononuclear cells from healthy subjects and patients with coronary heart disease. Clin. Chim. Acta. 332:2003;61-67
29. Marx N., Sukhova G.K., Collins T., et al. PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells. Circulation. 99:1999;3125-3131